Young people in the earliest phase of expression of psychopathology
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Two samples of adolescents / young adults aged 16-25 years with sub-diagnostic, subclinical stage 1b levels of depression and or psychosis (MADRS≥10 and/or CAPE≥12, and GAF<70, following the guidelines of McGorry et al [1] corresponding with approximately 15% of the general population) (n=132), fear (n=66), as well as a comparison group with no/low level of psychopathology (n=50) based on the rating-scores of psychopathology using questionnaires will be studied.
Exclusion criteria
Exclusion criteria: Exclusion criterion is receiving a current psychological or psychiatric treatment or significant need for care. Contra-indications for (f)MRI are use of pacemaker, metal implants, pregnancy or a history of claustrophobia. Past recovery from depression, psychosis or anxiety disorder is not an exclusion criterion as this would not impact the outcome measures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neuroimaging effects: The primary outcome measure in the intervention study is the pre/post intervention change of fMRI BOLD signal in the regions of interest involved in aversive learning, in reward learning and in anticipation of reward. The primary outcome measure in the observational study is the pre/post follow-up period change of fMRI BOLD signal in the regions of interest involved in aversive learning, in reward learning and in anticipation of reward. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes: 1. Reward experience; 2. Stress reactivity and salience reactivity as measured with ESM; 3. Cross-sectional associations between fMRI and ESM and psychopathology. Ancillary outcomes: Changes in depression, psychosis and fear psychopathology scores. | — |
Contacts
P. Debyelaan 25 Postbus 5800